The Vasculitis Syndromes

Size: px
Start display at page:

Download "The Vasculitis Syndromes"

Transcription

1 The Vasculitis Syndromes

2 Definition Inflammation and damage of blood vessels Single organ skin Several organ systems Primary Secondary Heterogeneity Overlap

3 Primary Vasculitis Syndromes Wegener s granulomatosis Churg-Strauss syndrome Polyarteritis nodosa Microscopic polyangitis Giant cell arteritis Takayasu s arteritis Henoch-Schönlein purpura Idiopthic cutaneous vasculitis Essential mixed cryoglobulinemia Behcet s syndrome Isolated vasculitis of the CNS Cogan s syndrome Kawasaki disease

4 Secondary Vasculitis Syndromes Drug-induced vasculitis Serum sickness Vasculitis associted with other primary diseases, infection, malignancy, rheumatic disease

5 Pathophysiology and Pathogenesis Immunpathogenic mechanisms Pathogenic immune complex formation and/or deposition:hepatitis B PAN, Hepatitis C Essential mixed cryoglob. Production of antineutrophilic cytoplasmic antibodies: Wegener s, Churg-Strauss, Microsc. polyang. Pathogenic T lymphocyte responses and granuloma formation:giant cell, Takayasu s, Wegener, Churg-Strauss

6 Approach to the patient: Vasculitis Unexplained systemic illness Angiogram of organs Definitive diagnosis biopsy of involved tissue

7 Wegener s granulomatosis

8 Incidence and Prevalence Prevalence: 3 per Age of onset: 40 years Primary vasculitis syndrome damage of vessels Immunopathogenic mechanisms ANCA= antineutrophil cytoplasmic antibody c-anca= cytoplasmic ANCA (diffuse, granular cytoplasmic staining by immunofluorescence microscopy) Detectable antibodies to proteinase-3 Granuloma formation

9 Pathology and pathogenesis Necrotizing vasculitis of small arteries and veins + granuloma formation Lung: multiple, bilateral, nodular cavitary infiltrates Biopsy: necrotizing granulomatous vasculitis Upper airway lasions: sinuses, nasopharynx Kidney: rapidly progressive crescentic

10 Clinical manifestations Upper airways 95% Purulent or bloody nasal discharge Nasal septal perforation Saddle nose deformity Serous oitis media, hearing loss Subglottic tracheal stenosis severe airway obstruction Pulmonary involvement:hemoptysis, dyspnea 85-90% Eye: scleritis, conjunctivitis, retroorbital mass laesion Skin: palpable purpura, papules, vesicles, subcutaneous nodules Heart: pericarditis, coronary vasculitis CNS: mononeuritis multiplex, cerebral vasculitis Kidney disease: 77%, proteinuria, hematuria, red blood cell casts, rapidly progressive renal failure

11 Laboratory findings ESR Mild anemia, leukocytosis, thrombocytosis 90% positive antiproteinase-3 c-anca

12 Diagnosis of WG Tissue biopsy: necrotizing granulomatous vasculitis c-anca positivity

13 Treatment of WG Cyclophosphamide induction for severe disease: 2 mg/kg per day orally + steroids Cyclophosphamide for 1 year following the induction of complete remission Prednisone 1 mg/kg per day Improvement: 90% Complete remissions: 75% Later relapses Remission maintenance: Azathioprine, Methotrexate 2 years past remission

14 Treatment of WG 2 Mycophenolate mofetil 1000 mg twice a day Rituximab (anti-cd20) Trimethoprim-sulfamethoxazole

15 Churg-Strauss syndrome

16 Definition Allergic angiitis and granulomatosis Asthma, peripheral and tissue eosinophilia, extravascular granuloma formation, vasculitis of multiple organs

17 Incidence and Prevalence 1-3 cases per million Onset: 48 years

18 Pathology and Pathogenesis Necrotizing vasculitis Small and medium-sized muscular erteries, capillaries, veins, and venules Granuloma formation Infiltration of the tissues with eosinophils Lung, skin, heart, kidney. Peripheralnervous system, GI

19 Clinical and Laboratory Manifesttions Asthma, pulmonary infiltrates Mononeuritis multiplex Allergic rhinitis and sinusitis Skin lesions: purpura, subcutaneous nodules Eosinophilia ESR p-anca = perinuclear ANCA (antimyeloperoxidase)

20 Diagnosis Asthma Peripheral blood eosinophilia Biopsy

21 Treatment Steroids Cyclophosphamide Survival rate:72%

22 Polyarteritis nodosa

23 Definition Multisystem, necrotizing vasculitis Small and medium-sized muscular arteries Renal and visceral arteries

24 Incidence and Prevalence Very uncommon disease

25 Pathology and Pathogenesis Segmental lesions Bifurcations and branching of arteries Aneurysmal dilatations up to 1 cm in size Kidney: arteritis without glomerulonephritis Hepatitis B antigenemia: 10-30% Circulating immune complexes composed of hepatitis B antigen

26 Clinical manifestations Fever, weight loss Kidney renal failure, hypertension Joint arthritis, arthralgia, myalgia Peripheral neuropathy, mononeuritis multiplex GI abdominal pain, bleeding, bowel infarction and perforation, liver infarction, pancreatic infarction Skin purpra, nodules, cutaneous infarcts, livedo reticularis Heart congestive heart failure, myocardial infarction, pericardiis Testicular and ovarian pain CNS cerebral vascular accident, seizure, altered mental status

27 Laboratory tests Leukocyte count ESR Anemia of chronic disease Hypergammaglobulinemia HBsAg pozitivity 30%

28 Diagnosis Vasculitis on biopsy material of involved organs Angiography aneurysms of small and medium-sized arteries

29 Treatment Steroid Cyclophosphamide PAN + Hepatitis B virus pozitivity: Antiviral drugs+ steroid+plasma exchange

30 Microscopic polyangitis Glomerulonephritis renal failure Pulmonary capillaritis hemoptysis Mononeuritis multiplex GI vasculitis Cutaneous vasculitis Age of onset: 57 years panca positivity 75%

31 Diagnosis and Treatment Kidney,lung: histologic evidence of vasculitis Steroid +Cyclophosphamide

32 Giant cell arteritis and Polymyalgia rheumatica

33 Definition Temporal arteritis or Cranial arteritis Inflammationof medium- and large-sized arteries Temporal artery Aorta and its main branches Polymyalgia rheumatica: pain in the muscles of the neck, shouldersm lower back >50 years

34 Clinical and Laboratory Manifestations Fever,anemia ESR Headache Temporal artery tender, thickened, nodular Ischemic optic neuropathy visual loss blindness Increased risk of aortic aneurysm dissection

35 Diagnosis Biopsy of the temporal artery Giant cell arteritis

36 Treatment Steroid: Prednisone40-60 mg/day 1 month Treatment for 2 years ESR Polymyalgia rheumatica: Prednisone mg/day ESR

37 Takayasu s arteritis Inflammatory and stenotic disease of medium- and large-sized arteries Aortic arch and its branches =Aortic arch syndrome Incidence: 1-2 cases/million/year Angiography

38 Frequency of angiographic abnormalities Subclavian: 93% Common carotid: 58% Abdominal aorta: 47% Aortic arch: 35% Vertebral: 35% Pulmonary: 10-40% Coronary < 10%

39 Clinical manifestetions Panarteritis with inflammatory mononuclear cell infiltrates Narrowing of the lumen Pulses absent ESR, anemia, gammaglobulin

40 Diagnosis Young woman Decrease or absence ofperipheral pulses Discrepancies in blood pressure Arterial bruits Arteriography irregular vessel walls, stenosis, poststenotic dilatation, aneurysm formation, occlusion, evidence of increased collateral circulation

41 Treatment Steroid: prednisone mg/day Methotrexate 25 mg/week Surgical correction of stenosed arteries

42 Henoch-Schönlein purpura Anaphylactoid purpura Palpable purpura over the buttocks and lower extremities Arthralgias GI signs colicky abdominal pain, melena/hematochesia Glomerulonephritis proteinuria, microscopic hematuria, red blood cell casts Small-vessel vasculitis Children 4-7 years Immune-complex deposition Serum IgA

43 Diagnosis Clinical symptoms Skin biopsy leukocytoclastic vasculitis

44 Treatment Do not require therapy Steroids: Prednisone 1 mg/kg/day

45 Idiopathic cutaneous vasculitis =Hypersensitivity vasculitis =Cutaneous leukocytoclastic vasculitis Dermis, small vessels Only skin involvement palpable purpura, chronic urticaria Diagnosis: biopsy vasculitis Etiology: drug, infection, underlying disease Treatment:microbe antimicrobal therapy, steroids

46 Essential mixed cryoglobulinemia Cryoglobulins: cold-precipitable monoclonal or polyclonal immunoglobulins Cutaneous vasculitis, palpable purpura, arthralgias, glomerulonephritis Hepatitis C infection Treatment:IFN-α, Ribavirin

47 Behcet s syndrome Recurrent, painful aphthous oral ulcerations in the oral cacity Recurrent genital ulcers Iritis Cutaneous lesions Treatment: topical steroids, Prednisone

48 Isolated vasculitis of the CNS Severe headache, focal neurologic defects Abnormal MRI of the brain Abnormal liquor Abnormal cerebral angiogram vasculitis Brain biopsy Treatment:Prednisone+Cyclophosphamid e

49 Kawasaki disease =Mucocutaneous lymph node syndrome Nonsuppurative cervical adenitis Children > 2 years Coronary artery aneurysms 25% Treatment:IVIG+ Aspirin

50 Raynaud s Phenomenon Episodic vasoconstriction inthe fingers and toes Tip of the nose and earlobes Cold exposure pallor cyanosis erythema rewarming of the fingers, vasoconstriction ischemia reperfusion Normal population: 3-5%, women Primary and/or secondary Nailbed cutaneous capillaries viewed stereoscopic microscope

51 Treatment Dress warmly, calcium channel blockers, ARBs (angiotensin II receptor blockers) Losartan, iv. prostaglandins, low-dose aspirin

PAEDIATRIC VASCULITIS

PAEDIATRIC VASCULITIS PAEDIATRIC VASCULITIS Lawrence Owino Okong o, Mmed (UoN); Mphil. (UCT). Lecturer, Department of Paediatrics and Child Health, University of Nairobi. Paediatrician/ Rheumatologist. OUTLINE Introduction

More information

Vasculitis local: systemic

Vasculitis local: systemic Vasculitis Inflammation of the vessel wall. Signs and symptoms: 1- local: according to the involved tissue 2- systemic:(fever, myalgia, arthralgias, and malaise) Pathogenesis 1- immune-mediated 2- infectious

More information

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis Case Presentation VASCULITIS The patient is a 24 year old woman who presented to the emergency room with left-sided weakness. She was confused and complained of a severe headache. She was noted to have

More information

VASCULITIS. Case Presentation. Case Presentation

VASCULITIS. Case Presentation. Case Presentation VASCULITIS Case Presentation The patient is a 24 year old woman who presented to the emergency room with left-sided weakness. She was confused and complained of a severe headache. She was noted to have

More information

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology Vasculitis Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology Disease Spectrum Hypersensitivity vasculitis/microscopic

More information

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis Edward Dwyer, M.D. Division of Rheumatology VASCULITIS is a primary inflammatory disease process of the vasculature Determinants of the Clinical Manifestations of : Target organ involved Size of vessel

More information

Vasculitis local: systemic

Vasculitis local: systemic Vasculitis Inflammation of the vessel wall. Signs and symptoms: 1- local: according to the involved tissue 2- systemic:(fever, myalgia, arthralgias, and malaise) Pathogenesis 1- immune-mediated inflammation

More information

Atlas of the Vasculitic Syndromes

Atlas of the Vasculitic Syndromes CHAPTER e40 Atlas of the Vasculitic Syndromes Carol A. Langford Anthony S. Fauci Diagnosis of the vasculitic syndromes is usually based upon characteristic histologic or arteriographic findings in a patient

More information

VASCULITIC SYNDROMES. Howard L. Feinberg, D.O., F.A.C.O.I., F.A.C.R. OPSC 2018

VASCULITIC SYNDROMES. Howard L. Feinberg, D.O., F.A.C.O.I., F.A.C.R. OPSC 2018 VASCULITIC SYNDROMES Howard L. Feinberg, D.O., F.A.C.O.I., F.A.C.R. OPSC 2018 2012 REVISED CHAPEL HILL CONSENSUS CONFERENCE Large vessel Takayasu arteritis Giant cell arteritis Medium Vessel Polyarteritis

More information

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi Vasculitis and Vasculitides OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi Definition Presence of leucocytes in the vessel wall with reactive damage

More information

SHO Teaching. Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth

SHO Teaching. Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth SHO Teaching Vasculitis Renal medicine Dr. Amir Bhanji Consultant Nephrologist, Q.A hospital, Portsmouth OUTLINE What is vasculitis Causes Classification Brief look into ANCA Associated Vasculitis (AAV)

More information

Overview. = inflammation of vessel wall. Symptoms and signs depend on the tissue of which the vessels are affected

Overview. = inflammation of vessel wall. Symptoms and signs depend on the tissue of which the vessels are affected Vasculitis (1+2) Overview = inflammation of vessel wall Symptoms and signs depend on the tissue of which the vessels are affected Often with systemic symptoms fever, myalgia, arthralgia, malaise etc. Most

More information

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Annual Rheumatology & Therapeutics Review for Organizations & Societies Annual Rheumatology & Therapeutics Review for Organizations & Societies Update on Granulomatosis with Polyangiitis (Wegener s) Learning Objectives Identify the clinical features of granulomatosis with

More information

Done by: Shatha Khtoum

Done by: Shatha Khtoum Done by: Shatha Khtoum Overview Vasculitis -Vasculitis is a general term for vessel wall inflammation -Symptoms and signs depend on the tissue of which the vessels are affected. (slide 2) -There are usually

More information

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward VASCULITIS SYNDROMES Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward ILLUSTRATED CASE 1 A 56 years old lady refered me for prolonged fever, arthritis

More information

December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis

December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis Lanny J. Rosenwasser, M.D. Dee Lyons/Missouri Endowed Chair in Immunology Research Professor of Pediatrics Allergy-Immunology Division Childrens

More information

Vasculitides in Surgical Neuropathology Practice

Vasculitides in Surgical Neuropathology Practice Vasculitides in Surgical Neuropathology Practice USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS

More information

A. Smržová. III. Interní klinika FN Olomouc nefrologická, revmatologická a endokrinologická

A. Smržová. III. Interní klinika FN Olomouc nefrologická, revmatologická a endokrinologická A. Smržová III. Interní klinika FN Olomouc nefrologická, revmatologická a endokrinologická Systemic vasculitis destructive inflamatory of the walls of blood vessels. Pathologist Inflammatory destruction

More information

RARE JUVENILE PRIMARY SYSTEMIC VASCULITIS

RARE JUVENILE PRIMARY SYSTEMIC VASCULITIS www.pediatric-rheumathology.printo.it RARE JUVENILE PRIMARY SYSTEMIC VASCULITIS WHAT IS IT? Vasculitis is an inflammation of blood vessels. Vasculitides cover a wide group of diseases. Primary vasculitis

More information

GRANULOMATOSIS WITH POLYANGIITIS

GRANULOMATOSIS WITH POLYANGIITIS What is granulomatosis with polyangiitis (GPA)? Granulomatosis with polyangiitis (GPA) is a form of vasculitis a family of rare disorders characterized by inflammation of the blood vessels, which can restrict

More information

VASCULITIS AND VASCULOPATHY

VASCULITIS AND VASCULOPATHY VASCULITIS AND VASCULOPATHY Mantosh S. Rattan @CincyKidsRad facebook.com/cincykidsrad Disclosure No relevant financial disclosures Outline Overview Referral pathways MR imaging Case examples Vasculitis

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A ANCA vasculitis. See Antineutrophil cytoplasmic antibody associated (ANCA) vasculitis Angiography 54 Antineutrophil cytoplasmic antibody correlation

More information

Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura)

Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura) Vasculitis (Polyarteritis Nodosa, Microscopic Polyangiitis, Wegener s Granulomatosis, Henoch- Schönlein Purpura) J. Charles Jennette Ronald J. Falk The kidneys are affected by a variety of systemic vasculitides

More information

vasculitis Patomorfologia vasculitis (arteritis) caused by infections vasculitis (arteritis) caused by infections

vasculitis Patomorfologia vasculitis (arteritis) caused by infections vasculitis (arteritis) caused by infections Patomorfologia Lecture 12 prof hab. n. med. Andrzej Marszałek VASCULITIS infectious vasculitis non-infectious causes: Aspergillus Rickettsiae vasculitis (arteritis) caused by infections Mucormycosis syphylis

More information

Vasculitis. Seth Mark Berney, MD Professor of Medicine Chief, Division of Rheumatology University of Arkansas for Medical Sciences

Vasculitis. Seth Mark Berney, MD Professor of Medicine Chief, Division of Rheumatology University of Arkansas for Medical Sciences Vasculitis Seth Mark Berney, MD Professor of Medicine Chief, Division of Rheumatology University of Arkansas for Medical Sciences History A 50 year old white male with a history of intravenous drug use

More information

Small Vessel Vasculitis

Small Vessel Vasculitis Small Vessel Vasculitis Paul A Brogan Professor of Vasculitis and Consultant Paediatric Rheumatologist Department of Rheumatology Institute of Child Health and Great Ormond St Hospital, London UK P.brogan@ucl.ac.uk

More information

The role of pathology in the diagnosis of systemic vasculitis

The role of pathology in the diagnosis of systemic vasculitis Clinical and Experimental Rheumatology 2007; 25: S52-S56 The role of pathology in the diagnosis of systemic vasculitis J.C. Jennette 1, R.J. Falk 2 1 Brinkhous Distinguished Professor and Chair of Pathology

More information

ST - segment Elevation Myocardial Infarction complicating an atypical Kawasaki disease

ST - segment Elevation Myocardial Infarction complicating an atypical Kawasaki disease ST - segment Elevation Myocardial Infarction complicating an atypical Kawasaki disease Raluca PRISECARU, Marc VINCENT, Steven VERCAUTEREN Brussels Heart Center, Brussels, Belgium Disclosure None Clinical

More information

Vasculitis Prof. Dr. med. Katharina Glatz Pathologie

Vasculitis Prof. Dr. med. Katharina Glatz Pathologie Vasculitis 08-21-2018 Prof. Dr. med. Katharina Glatz Pathologie Agenda Anatomy and histology Vasculitis: Chapel Hill Classification Examples Giant cell arteritis Single organ vasculitis Artery or Vein?

More information

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018. What is giant cell arteritis (GCA)? Giant cell arteritis (GCA) is a form of vasculitis a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage

More information

Small Vessel Vasculitis

Small Vessel Vasculitis Banff- Rocky Mountain Barry Kassen, MD, FRCPC,FACP Head, Division of Internal Medicine UBC/VGH/SPH Acting Head, Division of Community Internal Medicine November, 2009 Objectives 1. To understand small

More information

Systemic Sclerosis. Scleroderma

Systemic Sclerosis. Scleroderma Systemic Sclerosis Scleroderma Definition Chronic systemic disorder Unknown etiology Thickening of the skin = scleroderma Involvement of multiple internal organs Early stage: inflammation Later stage:

More information

Management of Acute Vasculitis. CMT teaching 3 rd June 2015 Caroline Wroe

Management of Acute Vasculitis. CMT teaching 3 rd June 2015 Caroline Wroe Management of Acute Vasculitis CMT teaching 3 rd June 2015 Caroline Wroe Vasculitis pub quiz Match the date with the event Dr Peter McBride, Scottish Otolaryngologist describes a disease of rapid destruction

More information

*HSP is a common vasculitis of small vessels with cutaneous & systemic complications. Its etiology is unknown& often follows URTIs.

*HSP is a common vasculitis of small vessels with cutaneous & systemic complications. Its etiology is unknown& often follows URTIs. BY Introduction The disease is eponymously named after Eduard heinrich Henoch (1820-1910), a German pediatrician, and his teacher Johann Lukas Schonlein (1793-1864), who described it in the 1860s. Cont

More information

A number of factors point to the likelihood of a person with RA developing RV:

A number of factors point to the likelihood of a person with RA developing RV: What is rheumatoid vasculitis (RV)? Rheumatoid vasculitis (RV) is a rare but serious complication of rheumatoid arthritis (RA) an inflammatory disease that causes severe joint pain and damage, and can

More information

CHECK LIST FORM-SCREENING

CHECK LIST FORM-SCREENING CHECK LIST FORM-SCREENING Participant Initials: Date of Birth: Evaluation Date: Were the following forms completed for this visit? Eligibility Form Done t Done Baseline medical History Form Done t Done

More information

Diagnostic Procedures for Vasculitis

Diagnostic Procedures for Vasculitis Diagnostic Procedures for Vasculitis Toshiharu Matsumoto, MD Clinical Professor of Department of Diagnostic Pathology Juntendo University Nerima Hospital, Tokyo, Japan Introduction In 1994, the International

More information

TAKAYASU S ARTERITIS. Second-stage symptoms include:

TAKAYASU S ARTERITIS. Second-stage symptoms include: What is Takayasu s arteritis (TAK)? Takayasu s arteritis (TAK) is a form of vasculitis a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage

More information

CENTRAL NERVOUS SYSTEM VASCULITIS

CENTRAL NERVOUS SYSTEM VASCULITIS What is central nervous system (CNS) vasculitis? Central nervous system (CNS) vasculitis is among a family of rare disorders characterized by inflammation of the blood vessels, which restricts blood flow

More information

CHECK LIST FORM-SCREENING

CHECK LIST FORM-SCREENING CHECK LIST FORM-SCREENING Participant Initials: Date of Birth: Evaluation Date: Were the following forms completed for this visit? Eligibility Form Done t Done Baseline medical History Form Done t Done

More information

Scleritis LEN V KOH OD

Scleritis LEN V KOH OD Scleritis LEN V KOH OD 2014 PUCO 1 Introduction A painful, destructive, and potentially blinding disorder Highly symptomatic High association with systemic disease Immunosuppresssive agents 2014 PUCO 2

More information

Rituximab treatment for ANCA-associated vasculitis in childhood

Rituximab treatment for ANCA-associated vasculitis in childhood Rituximab treatment for ANCA-associated vasculitis in childhood DISCLOSURE I have no relevant financial relationships to disclose Katharine Moore MD Nov 14, 2012 University of Colorado School of Medicine

More information

A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature

A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature 478 Bispebjerg Hospital, 2400 Copenhagen NV, Denmark S F Sørensen Hvidovre Hospital, Hvidovre, Denmark O Slot N Tvede Rigshospitalet, National University Hospital, Copenhagen, Denmark J Petersen Correspondence

More information

Cardiovascular Pathology

Cardiovascular Pathology Cardiovascular Pathology Duration: 03 Weeks (15 days) Concepts Objectives Activity Time Department Comments 3/SBM-3/01 Introduction to ischaemia, infarction, thrombosis stenosis / occlusion, embolism Atherosclerosis

More information

Glomerular pathology in systemic disease

Glomerular pathology in systemic disease Glomerular pathology in systemic disease Lecture outline Lupus nephritis Diabetic nephropathy Glomerulonephritis Associated with Bacterial Endocarditis and Other Systemic Infections Henoch-Schonlein Purpura

More information

CHECK LIST FORM-MONTH 27 (Please note Month 27 is from enrolment not randomisation)

CHECK LIST FORM-MONTH 27 (Please note Month 27 is from enrolment not randomisation) CHECK LIST FORM-MONTH 27 (Please note Month 27 is from enrolment not randomisation) Participant Initials: Date of Birth: Were the following forms completed for this visit? Follow Up Form Done t Done BVASWG

More information

VASCULITIS ACOI Robert L. DiGiovanni, DO, FACOI

VASCULITIS ACOI Robert L. DiGiovanni, DO, FACOI VASCULITIS ACOI 2018 Robert L. DiGiovanni, DO, FACOI robdsimc@tampabay.rr.com Disclosures NONE Vasculitis Clinicopathologic process characterized by inflammation of and damage to blood vessels. Vessel

More information

ANCA associated vasculitis in China

ANCA associated vasculitis in China ANCA associated vasculitis in China Min Chen Renal Division, Peking University First Hospital, Beijing 100034, P. R. China 1 General introduction of AAV in China Disease spectrum and ANCA type Clinical

More information

KAWASAKI DISEASE. What is Kawasaki disease? Causes

KAWASAKI DISEASE. What is Kawasaki disease? Causes What is Kawasaki disease? Kawasaki disease is a form of vasculitis a family of rare disorders characterized by inflammation of the blood vessels, which can restrict blood flow and damage vital organs and

More information

EDITORIAL. Issue Seventeen, October Editorial Team. Issue Seventeen. Info link

EDITORIAL. Issue Seventeen, October Editorial Team. Issue Seventeen. Info link EDITORIAL, October 2004 Welcome to the Spring 2004 Edition of InfoLink. The feature article in this edition has been written by Dr Rodger Laurent, Head of Department, PaLMS Rheumatology Laboratory. The

More information

29 Glomerular disease: an overview

29 Glomerular disease: an overview 29 Glomerular : an overview Renal Extra-renal Neurological changes Clinical syndromes pressure Sore throat (streptococcal) Rash Cardiac valve lesions Hemoptysis Asymptomatic or Acute Glomerulonephritis

More information

Year 2004 Paper one: Questions supplied by Megan

Year 2004 Paper one: Questions supplied by Megan QUESTION 53 Endothelial cell pathology on renal biopsy is most characteristic of which one of the following diagnoses? A. Pre-eclampsia B. Haemolytic uraemic syndrome C. Lupus nephritis D. Immunoglobulin

More information

AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS

AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS GRANULOMATOSIS WITH POLYANGIITIS (GPA), MICROSCOPIC POLYANGIITIS (MPA), and EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS What is ANCA-associated Vasculitis?

More information

Crescentic Glomerulonephritis (RPGN)

Crescentic Glomerulonephritis (RPGN) Crescentic Glomerulonephritis (RPGN) Background Rapidly progressive glomerulonephritis (RPGN) is defined as any glomerular disease characterized by extensive crescents (usually >50%) as the principal histologic

More information

ARTHRITIS FOUNDATION VASCULITIS

ARTHRITIS FOUNDATION VASCULITIS ARTHRITIS FOUNDATION Registered Nonprofit Organisation - No. 002-847 NPO Helpline No: 0861 30 30 30 VASCULITIS This information leaflet is published by the Arthritis Foundation as part of our continuing

More information

RATIONALE. K Without therapy, ANCA vasculitis with GN is associated. K There is high-quality evidence for treatment with

RATIONALE. K Without therapy, ANCA vasculitis with GN is associated. K There is high-quality evidence for treatment with http://www.kidney-international.org chapter 13 & 2012 KDIGO Chapter 13: Pauci-immune focal and segmental necrotizing glomerulonephritis Kidney International Supplements (2012) 2, 233 239; doi:10.1038/kisup.2012.26

More information

Vasculitis. Marwan Adwan. 4 th year MBBS. Consultant Rheumatologist. MBChB, MRCPI, MSc, MRCP (rheum)

Vasculitis. Marwan Adwan. 4 th year MBBS. Consultant Rheumatologist. MBChB, MRCPI, MSc, MRCP (rheum) Vasculitis 4 th year MBBS Marwan Adwan MBChB, MRCPI, MSc, MRCP (rheum) Consultant Rheumatologist Case 1 A 45 man presents with 3 wk hx of fever, fatigue, malaise, abdo pain and polyarthralgia. He noticed

More information

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J. Making Room for Rheumatology James J. Nocton, MD Disclosures I have nothing to disclose Rheumatic Diseases of Childhood Juvenile Idiopathic Arthritis (JIA) Systemic Lupus Erythematosus (SLE) Juvenile Dermatomyositis

More information

Takayasu s Arteritis: A Case Report With Global Arterial Involvement

Takayasu s Arteritis: A Case Report With Global Arterial Involvement 1 Case Report Takayasu s Arteritis: A Case Report With Global Arterial Involvement Waqas Ahmed, Zeeshan Ahmad* From Shifa International Hospital H-8/4, Islamabad, Pakistan Correspondence: Dr Waqas Ahmed,

More information

Case Presentation. By Eman El Sharkawy Ass. Professor of cardiology Alexandria University

Case Presentation. By Eman El Sharkawy Ass. Professor of cardiology Alexandria University Case Presentation By Eman El Sharkawy Ass. Professor of cardiology Alexandria University 6m old baby girl Past history : - At the age of 2m attack of fever, diarrhea, mouth ulcers, difficult breast feeding

More information

CUTANEOUS VASCULITIS. Katharine Warburton ST6 Dermatology

CUTANEOUS VASCULITIS. Katharine Warburton ST6 Dermatology CUTANEOUS VASCULITIS Katharine Warburton ST6 Dermatology AIMS Clinical cases introduction The theory Categorising cutaneous vasculitis Features presenting in the skin Mimics/pitfalls How to initially manage

More information

FAQ Identifying and enrolling participants

FAQ Identifying and enrolling participants FAQ Identifying and enrolling participants WHO IS ELIGIBLE - CASES? Patients with a new diagnosis of primary systemic vasculitis Patients suitable as cases are over 18 years with a new presentation or

More information

Update on nomenclature and classification of vasculitis

Update on nomenclature and classification of vasculitis Update on nomenclature and classification of vasculitis Mohammadreza Shakibi M.D. Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward Adolph Kussmaul (1822 1902) First Modern

More information

Functional vascular disorders

Functional vascular disorders Functional vascular disorders Raynaud s phenomenon Raynaud s phenomenon Refers to Intermittent,bilateral attacks of ischemia of the fingers or toes, and sometimes ears or nose. It clinically manifests

More information

Rheumatology Primer: What Labs and When

Rheumatology Primer: What Labs and When Rheumatology Primer: What Labs and When Irina Konon, MD Department of Internal Medicine Division of Rheumatology Medical College of Wisconsin Disclosures None 1 Objective Discuss principles of laboratory

More information

Vasculitis Update. A selective review of what s new. Dr Jonathan Akikusa MBBS FRACP

Vasculitis Update. A selective review of what s new. Dr Jonathan Akikusa MBBS FRACP Vasculitis Update A selective review of what s new Dr Jonathan Akikusa MBBS FRACP Consultant Paediatric Rheumatologist Royal Children s Hospital, Melbourne Honorary Research Fellow Murdoch Children s Research

More information

9/11/11. Temporal Arteritis. Background. Background. Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service

9/11/11. Temporal Arteritis. Background. Background. Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service Temporal Arteritis Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service 1 Background Giant Cell Arteritis Temporal Arteritis Cranial Arteritis Granulomatous Arteritis

More information

17 : 3. Renu Saigal, Amit Kansal, Jaipur ABSTRACT:

17 : 3. Renu Saigal, Amit Kansal, Jaipur ABSTRACT: 17 : 3 Approach to systemic Vasculitis ABSTRACT: Vasculitides are group of disorders characterized by immunoinflammatory injury to vessel wall leading to aneurysm, bleeding, stenosis, occlusion, thrombosis,

More information

Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis

Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis GLOMERULONEPHRITIDES Vivette D Agati Jai Radhakrishnan Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis Heavy Proteinuria Renal failure Low serum Albumin Hypertension

More information

Cerebrovascular Disease

Cerebrovascular Disease Neuropathology lecture series Cerebrovascular Disease Physiology of cerebral blood flow Brain makes up only 2% of body weight Percentage of cardiac output: 15-20% Percentage of O 2 consumption (resting):

More information

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens:

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens: Autoimmunity Reactivity to self antigens: Autoreactivity: Autoimmune Disease T cells B cells Leading to tissue damage or dysfunction Occurring in the absence of ongoing infection Epidemiology SLE Pathogenesis

More information

VCRC-OMERACT ANCA-Vasculitis Outcome Measure Initiative Comparative Outcome Measure Exercise-Training Cases

VCRC-OMERACT ANCA-Vasculitis Outcome Measure Initiative Comparative Outcome Measure Exercise-Training Cases Introduction to Training Cases The purpose of this preliminary exercise is to familiarize you with the rules and logistics of the five instruments under study. Please do not read the Training Cases until

More information

Autoimmunity. Autoimmune Disease

Autoimmunity. Autoimmune Disease Autoimmunity Reactivity to self antigens: T cells B cells Autoimmune Disease Autoreactivity: Leading to tissue damage or dysfunction Occurring in the absence of ongoing infection 1 SLE Pathogenesis Immune

More information

Review Article. Current concepts in Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated Vasculitis. Milind Aurangabadkar

Review Article. Current concepts in Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated Vasculitis. Milind Aurangabadkar Review Article Vidarbha Journal of Internal Medicine Volume 23 July 207 Current concepts in Anti-Neutrophil Cytoplasmic Antibody (ANCA) associated Vasculitis Milind Aurangabadkar ABSTRACT Anti-neutrophil

More information

Granulomatosis with Polyangiitis (Wegener s)

Granulomatosis with Polyangiitis (Wegener s) August 2011 Granulomatosis with Polyangiitis (Wegener s) Andrew Noll, Harvard Medical School, Year III Agenda Patient presentation Overview of granulomatosis with polyangiitis (Wegener s), abbreviated

More information

Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow

Neuropathology lecture series. III. Neuropathology of Cerebrovascular Disease. Physiology of cerebral blood flow Neuropathology lecture series III. Neuropathology of Cerebrovascular Disease Physiology of cerebral blood flow Brain makes up only 2% of body weight Percentage of cardiac output: 15-20% Percentage of O

More information

The systemic vasculitides were traditionally classified. Treatment of ANCA-associated Systemic Vasculitis. H. Michael Belmont, M.D.

The systemic vasculitides were traditionally classified. Treatment of ANCA-associated Systemic Vasculitis. H. Michael Belmont, M.D. 60 Treatment of ANCA-associated Systemic Vasculitis H. Michael Belmont, M.D. Abstract The antineutrophil cytoplasmic antibodies (ANCA)-associated small vessel vasculitides include Wegener s granulomatosis,

More information

Guideline on the clinical management of Henoch Schonlein Purpura (HSP)

Guideline on the clinical management of Henoch Schonlein Purpura (HSP) Guideline on the clinical management of Henoch Schonlein Purpura (HSP) Purpose To ensure a standardised approach in the management of children with HSP in southern Derbyshire. Scope The scope of this guideline

More information

SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018

SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018 SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018 OUTLINE Renal involvement in vasculitis Curr Rheumatol Rep 2013 Renal involvement in ANCA vasculitis GN***:

More information

Blood and Circulation Module Year 3 Semester 1

Blood and Circulation Module Year 3 Semester 1 Blood and Circulation Module Year 3 Semester 1 Duration: 03 Weeks (15 days) Concepts Objectives Activity Time Department 1. 2006-3/SBM-3/01 Introduction to ischaemia, infarction, thrombosis stenosis /

More information

DIABETES MELLITUS. Kidney in systemic diseases. Slower the progression: Pathology: Patients with diabetes mellitus are prone to other renal diseases:

DIABETES MELLITUS. Kidney in systemic diseases. Slower the progression: Pathology: Patients with diabetes mellitus are prone to other renal diseases: Kidney in systemic diseases Dr. Badri Paudel The kidneys may be directly involved in a number of multisystem diseases or secondarily affected by diseases of other organs. Involvement may be at a prerenal,

More information

Histopathology: Glomerulonephritis and other renal pathology

Histopathology: Glomerulonephritis and other renal pathology Histopathology: Glomerulonephritis and other renal pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you

More information

HYPERTENSIVE VASCULAR DISEASE

HYPERTENSIVE VASCULAR DISEASE HYPERTENSIVE VASCULAR DISEASE Cutoffs in diagnosing hypertension in clinical practice sustained diastolic pressures >90 mm Hg, or sustained systolic pressures >140 mm Hg Malignant hypertension A small

More information

Shawkat Michel, M.D.

Shawkat Michel, M.D. Vasculitis / Polyarteritis nodosa (PAN) Shawkat Michel, M.D. Case presentation: 87 yo, wf was referred in May 1998 with decreased VA OD and photophobia > one year duration. The patient had been on topical

More information

ANCA-associated systemic vasculitis (AASV)

ANCA-associated systemic vasculitis (AASV) PAPER 2007 Royal College of Physicians of Edinburgh ANCA-associated systemic vasculitis (AASV) 1 DC Kluth, 2 J Hughes 1 Reader in Nephrology, MRC Centre for Inflammation Research, University of Edinburgh,

More information

Lung diseases of Vascular Origin. By: Shefaa Qa qqa

Lung diseases of Vascular Origin. By: Shefaa Qa qqa Lung diseases of Vascular Origin By: Shefaa Qa qqa Pulmonary Hypertension Pulmonary hypertension is defined as a mean pulmonary artery pressure greater than or equal to 25 mm Hg at rest. Based on underlying

More information

EULAR/ERA-EDTA recommendations for the management of ANCAassociated

EULAR/ERA-EDTA recommendations for the management of ANCAassociated EULAR/ERA-EDTA recommendations for the management of ANCAassociated vasculitis Dr. Meharunnisha Syed III year DNB Resident (General Medicine) Narayana Health-MSH Fifteen recommendations were developed,

More information

RAPIDLY FAILING KIDNEYS. Dr Paul Johny 2 nd yr DNB Medicine Resident

RAPIDLY FAILING KIDNEYS. Dr Paul Johny 2 nd yr DNB Medicine Resident RAPIDLY FAILING KIDNEYS Dr Paul Johny 2 nd yr DNB Medicine Resident Mr Z 67yrs old Occupation : Retired officer from electricity board Chief complaints : Fever : 5 days Right lower limb swelling and pain

More information

CASE 4 A RARE CASE OF INTRALUMINAL GLOMERULAR CAPILLARY DEPOSITS

CASE 4 A RARE CASE OF INTRALUMINAL GLOMERULAR CAPILLARY DEPOSITS CASE 4 A RARE CASE OF INTRALUMINAL GLOMERULAR CAPILLARY DEPOSITS DR ANNIE JOJO, Dr Seethalekshmy N V, Dr Nanda Kachare DEPARTMENT OF PATHOLOGY, AMRITA INSTITUTE OF MEDICAL SCIENCES, KOCHI. 54 yrs female,

More information

HEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT

HEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT HEMORRHAGIC BULLOUS HENOCH- SCHONLEIN PURPURA: A CASE REPORT Nirmala Ponnuthurai, Sabeera Begum, Lee Bang Rom Paediatric Dermatology Unit, Institute of Paediatric, Hospital Kuala Lumpur, Malaysia Abstract

More information

Tell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital

Tell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital Tell me more about vasculitis Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital Talk overview Case study ANCA-associated vasculitis What is ANCA vasculitis? What causes ANCA

More information

Kawasaki Disease. 1:45 2:30 p.m. James Nocton, MD Benjamin Goot, MD. Children s Specialty Group. All rights reserved.

Kawasaki Disease. 1:45 2:30 p.m. James Nocton, MD Benjamin Goot, MD. Children s Specialty Group. All rights reserved. Kawasaki Disease 1:45 2:30 p.m. James Nocton, MD Benjamin Goot, MD Disclosures We have no relevant financial relationships to disclose. Objectives Describe the characteristic signs and symptoms of Kawasaki

More information

Clinical characteristics and outcome of vasculitides

Clinical characteristics and outcome of vasculitides GENERAL SECTION ORIGINAL ARTICLE Clinical characteristics and outcome of vasculitides Buddhi Prasad Paudyal, 1 Madhu Gyawalee 2 ISSN: 2091-2749 (Print) 2091-2757 (Online) Correspondence Dr. Buddhi Prasad

More information

NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES

NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES Leslie M. Scoutt, MD, FACR Professor of Diagnostic Radiology & Surgery Vice Chair, Dept of Radiology & Biomedical Imaging Chief, Ultrasound Section

More information

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center Boston, MA Diagnostic Tests in Rheumatic Disease: What's Old,

More information

Prepared by Sarah Bozeman, MD, University of Mississippi Healthcare, and John Seyerle, Ohio State University

Prepared by Sarah Bozeman, MD, University of Mississippi Healthcare, and John Seyerle, Ohio State University Allergy and Immunology Review Corner: Chapter 53 of Middleton s Allergy Principles and Practice, Seventh Edition, edited by N. Franklin Adkinson, et al. Chapter 53: Occupational Asthma Prepared by Sarah

More information

Content. Polyarteritis nodosa. Vasculitis. Giant cell arteritis. Primary cerebral angiitis. Other autoimmune CNS disease.

Content. Polyarteritis nodosa. Vasculitis. Giant cell arteritis. Primary cerebral angiitis. Other autoimmune CNS disease. Content Other autoimmune CNS disease Philippe Demaerel Vasculitis Systemic lupus erythematosus Wegener granulomatosis Behçet disease Rhombencephalitis - CLIPPERS Neurosarcoidosis Langerhans cell histiocytosis

More information

UNFOLDING NATURE S ORIGAMI: MEDICAL TREATMENT OF TAKAYASU ARTERITIS AND GIANT CELL ARTERITIS

UNFOLDING NATURE S ORIGAMI: MEDICAL TREATMENT OF TAKAYASU ARTERITIS AND GIANT CELL ARTERITIS UNFOLDING NATURE S ORIGAMI: MEDICAL TREATMENT OF TAKAYASU ARTERITIS AND GIANT CELL ARTERITIS CanVasc meeting Montreal Nov 22 2012 Patrick Liang Service de rhumatologie Centre Hospitalier Universitaire

More information

Pharmacy Management Drug Policy

Pharmacy Management Drug Policy SUBJECT: : Nucala (mepolizumab), Cinqair (reslizumab), & Fasenra (benralizumab) POLICY NUMBER: Pharmacy-62 EFFECTIVE DATE: 12/15 LAST REVIEW DATE: 3/5/2018 If the member s subscriber contract excludes

More information

Plan. Sarcoidosis 21/07/2017. Sarcoidosis Liver involvement. Sarcoidosis GI involvement. Sarcoidosis Diagnosis

Plan. Sarcoidosis 21/07/2017. Sarcoidosis Liver involvement. Sarcoidosis GI involvement. Sarcoidosis Diagnosis Belfast Pathology 2017 Gastrointestinal tract involvement by systemic disease 21.6.17 Dr Adrian C. Bateman University Hospital Southampton NHS Foundation Trust, UK Plan Dermatological conditions Chronic

More information